Journey Medical Corporation Announces Publication In The Journal Of The American Medical Association - Dermatology Of The Phase 3 Clinical Trial Results Of Emrosi™ (Dfd-29) To Treat Rosacea
JOURNEY MEDICAL CORPORATION ANNOUNCES PUBLICATION IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION - DERMATOLOGY OF THE PHASE 3 CLINICAL TRIAL RESULTS OF EMROSI™ (DFD-29) TO TREAT ROSACEA
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.